HPV associated oropharyngeal tumor incidence.

HPV associated oropharyngeal tumor incidence. - HPV-OPSCC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028010

Enrollment

10000

Registered

2022-01-31

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C01 C02.0 C02.4 C02.8 C02.9 C05.1 C05.2 C05.8 C05.9 C09.0 C09.1 C09.8 C09.9 C10.0 C10.1 C10.2 C10.3 C10.8 C10.9 C14.0 C14.2 C14.8

Interventions

Group 1: Patients with initial diagnosis of oropharyngeal tumors.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed oropharyngeal tumors are included. The collection and analysis of the data is done according to DSGVO. Both HPV-positive oropharyngeal tumors as well as HPV-negative oropharyngeal tumors are included.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
An epidemiologic survey of HPV-associated oropharyngeal tumors.	—

Secondary

Measure	Time frame
Impact of HPV vaccination on the incidence of HPV-associated oropharyngeal tumors.	—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactNicholas Bevis

Hals-Nasen-Ohrenheilkunde

nicholas.bevis@med.uni-goettingen.de+495513963771

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026